Talphera (TLPH) Restructuring Costs (2015)

Talphera (TLPH) posted quarterly Restructuring Costs of $2000.0 for Q2 2015, down 99.73% quarter-over-quarter from $754000.0 in Q1 2015.

Talphera (TLPH) Restructuring Costs (2015) Analysis & Trends

Talphera's Restructuring Costs history runs 1 years deep, the most recent figure standing at $2000.0 for Q2 2015.

In Q2 2015, Restructuring Costs changed N/A year-over-year to $2000.0; the TTM figure through Dec 2015 stood at $756000.0 (changed N/A YoY), while the FY2015 annual figure was $756000.0, changed N/A from the prior year.
Restructuring Costs for Q2 2015 stood at $2000.0, down from $754000.0 in the prior quarter.
The five-year high for Restructuring Costs was $754000.0 in Q1 2015, with the low at $2000.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Talphera	89.88 Mn	89.88 Mn	-

Download Data

Date	Value
Jun 30, 2015	2,000.00
Mar 31, 2015	754,000.00